Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11702389 Piperidine derivatives as HDAC1/2 inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
1
Current Assignee
Regenacy Pharmaceuticals
Regenacy Pharmaceuticals
1
Date Filed
February 24, 2021
1
Date of Patent
July 18, 2023
1
Patent Applicant
Regenacy Pharmaceuticals
Regenacy Pharmaceuticals
1
Patent Application Number
17184118
1
Patent Citations
‌
US Patent 8394810 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
1
‌
US Patent 8598168 Inhibitors of histone deacetylase
1
‌
US Patent 8609678 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
1
‌
US Patent 8614223 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
1
‌
US Patent 9096549 Selective HDAC3 inhibitors
1
‌
US Patent 9139583 Selective HDAC3 inhibitors
1
‌
US Patent 9145412 Selective HDAC1 and HDAC2 inhibitors
1
‌
US Patent 9249087 HDAC inhibitors and therapeutic methods using the same
1
‌
US Patent 9278963 Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
1
‌
US Patent 9421212 Selective HDAC1 and HDAC2 inhibitors
1
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
11702389
1
Patent Primary Examiner
‌
Theodore R. Howell
1
CPC Code
‌
A61K 31/445
1
‌
A61P 35/00
1
‌
A61K 31/4164
1
‌
A61P 37/00
1
‌
A61P 35/02
1
‌
A61K 31/4178
1
Industry
Request Data

Find more entities like US Patent 11702389 Piperidine derivatives as HDAC1/2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.